Amplification or epigenetic modification of TERT (rs7734992, 5p15.33) plays a crucial role in ccRCC by maintaining cellular immortality, with HIF1A and EPAS1 regulating TERT expression, enhancing tumour survival under hypoxic conditions45. Here, HIF1A is linked to nonpapillary renal cell carcinoma.